Emerging trends in virus and virus-like particle gene therapy delivery to the brain
Open Access
- 20 July 2024
- journal article
- review article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 35 (3) , 102280
Abstract
No abstract availableKeywords
Funding Information
- Batten Disease Support and Research Association Australia
- Retina Australia
- National Health and Medical Research Council
This publication has 196 references indexed in Scilit:
- Restricted transport of anti‐transferrin receptor antibody (OX26) through the blood–brain barrier in the ratJournal of Neurochemistry, 2001
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsGene Therapy, 2001
- Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral deliveryHuman Molecular Genetics, 2001
- Production and Neurotropism of Lentivirus Vectors Pseudotyped with Lyssavirus Envelope GlycoproteinsMolecular Therapy, 2001
- Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In VivoJournal of Virology, 2001
- VSV-G Pseudotyped Lentiviral Vector Particles Produced in Human Cells Are Inactivated by Human SerumMolecular Therapy, 2000
- Noninvasive gene targeting to the brainProceedings of the National Academy of Sciences, 2000
- An Antibody-Avidin Fusion Protein Specific for the Transferrin Receptor Serves as a Delivery Vehicle for Effective Brain Targeting: Initial Applications in Anti-HIV Antisense Drug Delivery to the BrainThe Journal of Immunology, 1999
- Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia virusesJournal of Virology, 1992
- Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.Proceedings of the National Academy of Sciences, 1991